Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01185002 · ClinicalTrials.gov registry record · Phase 2

Evaluation of PillCam® Colon 2 Capsule Endoscopy Regimen

A Phase 2 study of Colonoscopy and Endoscopy, sponsored by Medtronic - MITG.

Completed
Registry status
Phase 2
Development phase
80
Enrollment target
7
Study locations

NCT01185002 is a Phase 2 study of Colonoscopy and Endoscopy that has completed, run by Medtronic - MITG. The registered enrollment target is 80 participants, below the 498-participant average among 20 other Colonoscopy trials with a reported enrollment target (84% lower). The trial reports 7 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01185002, a Phase 2 study of Colonoscopy and Endoscopy, has completed, sponsored by Medtronic - MITG.

COMPLETED
Registry status
Phase 2
Development phase
80 participants
Enrollment target
7
Study locations

Study Summary

The purpose of the study is to test the effect of a bowel preparation and boosts regimen on PillCam® procedure, colon cleanliness and capsule excretion time.

Conditions Studied

Interventions

  • OTHER PillCam® COLON 2 procedure using MgC boosts
  • OTHER PillCam® COLON 2 procedure using Suprep boosts
  • OTHER PillCam® COLON 2 procedure using reduced dose of Suprep boosts

Study Locations (7)

Alabama

  • Alabama Digestive Disorders Center - Huntsville

Indiana

  • Division of Gastroenterology Indiana University Medical Center - Indianapolis

New York

  • Research Associates of New York - New York

North Carolina

  • University of North Carolina Division of Digestive Disease - Chapel Hill

Ohio

  • Digestive Care, Inc. - Beavercreek

Tennessee

  • Franklin Gastroenterology - Franklin

Virginia

  • Gastroenterology Associates of Tidewater - Chesapeake

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2010-07
Est. Completion 2011-06
Phase Phase 2

Sponsor

Medtronic - MITG

119 total trials

What the Registry Record Tells You About NCT01185002

The ClinicalTrials.gov registry entry for NCT01185002 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 498-participant average among 20 other Colonoscopy trials with a reported enrollment target (84% lower). The listed sponsor is Medtronic - MITG, which has 119 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Colonoscopy appearing as the primary indexed condition, and to 3 interventions - of which PillCam® COLON 2 procedure using MgC boosts is the first listed.

NCT01185002 reports 7 study locations spanning 7 distinct geographic areas - top geographies include Alabama, Indiana, New York.

Frequently Asked Questions

What is clinical trial NCT01185002 about?

NCT01185002 is a clinical study titled "Evaluation of PillCam® Colon 2 Capsule Endoscopy Regimen". The purpose of the study is to test the effect of a bowel preparation and boosts regimen on PillCam® procedure, colon cleanliness and capsule excretion time.

What is the current status of trial NCT01185002?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 80 participants. The study started on 2010-07. Estimated completion is 2011-06.

What conditions does trial NCT01185002 study?

This clinical trial studies the following conditions: Colonoscopy, Endoscopy.

What interventions are being tested in trial NCT01185002?

The interventions under investigation include: PillCam® COLON 2 procedure using MgC boosts (OTHER), PillCam® COLON 2 procedure using Suprep boosts (OTHER), PillCam® COLON 2 procedure using reduced dose of Suprep boosts (OTHER).

Who is sponsoring clinical trial NCT01185002?

This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01185002 being conducted?

This trial has 7 study locations across Alabama, Indiana, New York, North Carolina, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Colonoscopy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.